Revelation Biosciences
$0.01
19
+$0+0% Wednesday 17:13
Statistics
Day High
0.01
Day Low
0.01
52W High
0.01
52W Low
0.01
Volume
2,000
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
8MayExpected
Expected EPS
-1.15
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-15.04MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow REVBW. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap10.61B
BioNTech
BNTX
Mkt Cap24.99B
Novavax
NVAX
Mkt Cap1.36B
Pfizer
PFE
Mkt Cap140.15B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Gilead Sciences
GILD
Mkt Cap148.78B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
AMGEN
AMGN
Mkt Cap160.66B
Astrazeneca
AZN
Mkt Cap256.58B
About
Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as SARS-CoV-2 comprising its variants, influenza A and B, parainfluenza, rhinovirus, and RSV, as well as is being developed for other indications comprising allergic rhinitis and chronic nasal congestion. It also develops REVTx-200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for immunity; and REVDx-501, a rapid home use diagnostic to detect respiratory viral infection. The company was founded in 2019 and is based in New York, New York.
Show more...
CEO
Mr. James M. Rolke
Employees
8
Country
US
ISIN
US76135L1199
Listings
0 Comments
Share your thoughts
FAQ
What is Revelation Biosciences stock price today?▼
The current price of REVBW is $0.01 USD — it has increased by +0% in the past 24 hours. Watch Revelation Biosciences stock price performance more closely on the chart.
What is Revelation Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Revelation Biosciences stocks are traded under the ticker REVBW.
Is Revelation Biosciences stock price growing?▼
REVBW stock has risen by +1.27% compared to the previous week, the month change is a -13.04% fall, over the last year Revelation Biosciences has showed a -27.27% decrease.
When is the next Revelation Biosciences earnings date?▼
Revelation Biosciences is going to release the next earnings report on May 08, 2026.
What were Revelation Biosciences earnings last quarter?▼
REVBW earnings for the last quarter are -1.65 USD per share, whereas the estimation was -3.66 USD resulting in a +54.92% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Revelation Biosciences revenue for the last year?▼
Revelation Biosciences revenue for the last year amounts to 0 USD.
What is Revelation Biosciences net income for the last year?▼
REVBW net income for the last year is -15.04M USD.
How many employees does Revelation Biosciences have?▼
As of April 02, 2026, the company has 8 employees.
In which sector is Revelation Biosciences located?▼
Revelation Biosciences operates in the Health Care sector.
When did Revelation Biosciences complete a stock split?▼
The last stock split for Revelation Biosciences was on February 01, 2023 with a ratio of 1:35.
Where is Revelation Biosciences headquartered?▼
Revelation Biosciences is headquartered in San Diego, US.